[The prevalence of antibodies against hepatitis B abs c virus in odontology students]. / Prevalencia de anticuerpos contra los virus de hepatitis B y C en estudiantes de odontología.

UNLABELLED: It is accepted that the practice of odontology implies a risk of BBV and HCV transmission but the study of does not. This work tries to determine the prevalence of HBv Ac and HCV Ac (by ELISA) in odontology students and whether there is any relation to the year of study and/or the presence of other risk factors. 188 students in their last three years of studies were investigated, all the participants filled out a clinical epidemiological form. 89 women (47.3%) and 99 men (52.7%), x age was 24.8. 50 (26.7%) had other risk factors. 160 (85.1%) fulfilled biosecurity norms and 40 (21.2%) had a labour accident. RESULTS: None of the analyzed sera were positive for HCV Ac (0%) and 1 was positive for HbcAc. CONCLUSION: The prevalence of HBv Ac and HCV Ac is extremely low with no relation to the year of study or any other risk factors.

Prevalencia de anticuerpos contra los virus de hepatitis B y C en estudiantes de ondontología / The prevalence of antibodies against hepatitis B abs c virus in odontology

It is accepted that the practice of odontology implies a risk of BBV and HCV transmission but the study of does not. This work tries to determine the prevalence of HBv Ac and HCV Ac (by ELISA) in odontology students and whether there is any relation to the year of study and/or the presence of other risk factors. 188 students in their last three years of studies were investigated, all the participants filled out a clinical epidemiological form. 89 women (47.3%) and 99 men (52.7%), x age was 24.8. 50 (26.7%) had other risk factors. 160 (85.1%) fulfilled biosecurity norms and 40 (21.2%) had a labour accident. RESULTS: None of the analyzed sera were positive for HCV Ac (0%) and 1 was positive for HbcAc. CONCLUSION: The prevalence of HBv Ac and HCV Ac is extremely low with no relation to the year of study or any other risk factors

Prevalencia de anticuerpos contra los virus de hepatitis B y C en estudiantes de ondontología / The prevalence of antibodies against hepatitis B abs c virus in odontology

It is accepted that the practice of odontology implies a risk of BBV and HCV transmission but the study of does not. This work tries to determine the prevalence of HBv Ac and HCV Ac (by ELISA) in odontology students and whether there is any relation to the year of study and/or the presence of other risk factors. 188 students in their last three years of studies were investigated, all the participants filled out a clinical epidemiological form. 89 women (47.3%) and 99 men (52.7%), x age was 24.8. 50 (26.7%) had other risk factors. 160 (85.1%) fulfilled biosecurity norms and 40 (21.2%) had a labour accident. RESULTS: None of the analyzed sera were positive for HCV Ac (0%) and 1 was positive for HbcAc. CONCLUSION: The prevalence of HBv Ac and HCV Ac is extremely low with no relation to the year of study or any other risk factors (AU)

Prevalencia de anticuerpos contra los virus de hepatitis B y C en estudiantes de odontología. / [The prevalence of antibodies against hepatitis B abs c virus in odontology students]

It is accepted that the practice of odontology implies a risk of BBV and HCV transmission but the study of does not. This work tries to determine the prevalence of HBv Ac and HCV Ac (by ELISA) in odontology students and whether there is any relation to the year of study and/or the presence of other risk factors. 188 students in their last three years of studies were investigated, all the participants filled out a clinical epidemiological form. 89 women (47.3

) and 99 men (52.7

), x age was 24.8. 50 (26.7

) had other risk factors. 160 (85.1

) fulfilled biosecurity norms and 40 (21.2

) had a labour accident. RESULTS: None of the analyzed sera were positive for HCV Ac (0

) and 1 was positive for HbcAc. CONCLUSION: The prevalence of HBv Ac and HCV Ac is extremely low with no relation to the year of study or any other risk factors.

Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study.

The objectives of this study were to investigate the prevalence of infections with hepatotrophic viruses in an anti-human immunodeficiency virus (HIV)-positive population from Buenos Aires and to compare it among the main risk groups for HIV infection. Four hundred and eighty-four consecutive patients attending the HIV outpatients clinic were studied: 359 men and 125 women, median age 29 years (range 16-67 years); 35.5% had presented acquired immune deficiency syndrome (AIDS)-defining conditions. Two hundred and thirty-four patients were intravenous drug users (IVDU), 99 had homosexual and 142 heterosexual preference, seven had received blood transfusions and two had no risk factors. Hepatitis B surface antigen (HBsAg), and antibodies to hepatitis B core antigen (HBcAb) and to hepatitis C virus (anti-HCV) were investigated in all patients; antibodies to HBsAg (HBsAb) and IgG antibodies to hepatitis D virus (anti-HDV) in all HBcAb-positive patients; hepatitis B e antigen and antibodies to HBeAg (HBeAg) in all HBsAg-positive patients; IgG antibodies to hepatitis A virus (anti-HAV) in the first 307 patients; and IgG antibodies to hepatitis E virus (anti-HEV) in the first 91 patients. As control groups, contemporary voluntary blood donors were studied for prevalence of HAV, HBV, HCV and HEV. The percentages of HBcAb, HBsAg, anti-HCV and anti-HEV (58.5, 14.5, 58.5 and 6.6%, respectively) were significantly higher in anti-HIV-positive patients than in control groups (3.2, 0.5, 1.0 and 1.8%, respectively) (P = 0.000). The prevalence of HBcAb was significantly higher in IVDU (72.6%) than in heterosexuals (33.8%) (P = 0.0001) and in homosexuals (59.6%) (P = 0.0189). The percentage of HBsAg was significantly higher in IVDU (19.2%) than in heterosexuals (6.3%) (P = 0.0004). Anti-HCV was significantly higher in IVDU (92.3%) than in homosexuals (14.1%) and in heterosexuals (33.1%) (P = 0.000 in both cases). The prevalence of anti-HDV was relatively low (1.9%). There was no difference in the percentage of anti-HAV between HIV-positive and negative subjects. In conclusion, there is a high prevalence of HBV and HCV infections in HIV-positive patients from our area. Drug use is the main route of transmission, but prevalence of HCV in patients with, probably, sexually acquired HIV infection is also higher than in the control group. The increased prevalence of HEV infection in HIV-positive individuals is another provocative finding that warrants further study.

[HCV and HBV prevalence in hemodialyzed pediatric patients. Multicenter study]. / Prevalencia de HCV y HBV en pacientes pediátricos hemodializados. Estudio multicéntrico.

Hemodialized pediatric patients are a risk population for the hepatitis B and C virus infection. The aim of this paper was to study the serum prevalence of HBV and HCV infection in hemodialized children. We study 61 pediatric patients at hemodialisis, 12 on renal transplant, range between 2 and 20 years old (mean: 12.9 years), 23 male and 38 female. The specific anti-HCV IgC were measured by enzyme immunoassay (ELISA Abbott) and confirmed by LIA-TEK (Organon). The anti-HBV were measured by ELISA Abbott and transaminases by cinetic method (ASAT: 29 UI/L and ALT: 33 UI/L). The 19.7% of studied children were HCV (+) and 29.5% were HBV (+), 38.9% of them were HbsAg (+) and 50% anti-HBs (+). The HCV and HBV infection was more elevated in relation to the transfusion number and the hemodilisis time. The elevation of ALT/ASAT activity isn't a right infection index for HCV and HBV in this children.

Prevalencia de HCV y HBV en pacientes pediatricos hemodializados: estudio multicentrico / HCV and HBV prevalence in hemodialyzed pediatric patients: multicenter study

Los pacientes Hd constituyen una población de riesgo para la infección por los virus de las hepatitis B y C. El objetivo de este trabajo fue evaluar la prevalencia de la infección por HCV y HBV en un corte de una población de niños hemodializados. Se estudiaron 61 pacientes pediátricos en hemodiálisis, 12 de los cuales eran Tx, con edades comprendidas entre 2 y 20 años (media: 12,9), 23 varones y 38 mujeres. Se determinaron los anticuerps anti-HCV IgG por enzimoinmunoensayo (EIE) (Abbott 2 generación) y como método confirmatorio se utilizó inmunoblotting de péptidos sintéticos linearizados (LIA-TEK) (Organon). La detección de los marcadores para HBV fue por EIE y el nivel de actividad de las transaminasas se determinó por método cintético. El 19,7 por ciento de los niños estudiados fueron HCV positivos y el 29,5 por ciento fueron HBV positivos, de los cuales el 38,9 por ciento fueron HBsAg positivos el 50 por ciento Anti-HBs positivos. La infección por HCV y HBV se vió incrementada en relación al número de transfusiones y al tiempo de inclusión en Hd. La elevación de nivel de actividad de las transaminasas no fue un buen índice de infección para HBV y HCV en estos pacientes.

Prevalencia de HCV y HBV en pacientes pediatricos hemodializados: estudio multicentrico / HCV and HBV prevalence in hemodialyzed pediatric patients: multicenter study

Los pacientes Hd constituyen una población de riesgo para la infección por los virus de las hepatitis B y C. El objetivo de este trabajo fue evaluar la prevalencia de la infección por HCV y HBV en un corte de una población de niños hemodializados. Se estudiaron 61 pacientes pediátricos en hemodiálisis, 12 de los cuales eran Tx, con edades comprendidas entre 2 y 20 años (media: 12,9), 23 varones y 38 mujeres. Se determinaron los anticuerps anti-HCV IgG por enzimoinmunoensayo (EIE) (Abbott 2 generación) y como método confirmatorio se utilizó inmunoblotting de péptidos sintéticos linearizados (LIA-TEK) (Organon). La detección de los marcadores para HBV fue por EIE y el nivel de actividad de las transaminasas se determinó por método cintético. El 19,7 por ciento de los niños estudiados fueron HCV positivos y el 29,5 por ciento fueron HBV positivos, de los cuales el 38,9 por ciento fueron HBsAg positivos el 50 por ciento Anti-HBs positivos. La infección por HCV y HBV se vió incrementada en relación al número de transfusiones y al tiempo de inclusión en Hd. La elevación de nivel de actividad de las transaminasas no fue un buen índice de infección para HBV y HCV en estos pacientes. (AU)